TCR Therapy market Professional Survey Report by 2035
Growing burden and unaddressed complex treatment needs of cancer patients have paved the way for more effective, safe, and versatile alternatives, such as TCR therapies.
Driven by Kimmtrak® approval, promising development pipeline and encouraging clinical trial results, the TCR- based therapy market is anticipated to witness significant growth in the mid to long-term. The financial opportunity within the TCR-based therapy market has been analyzed across the following segments:
Target Indication(s)
Nasopharyngeal Carcinoma
Multiple Myeloma
Head and Neck Carcinoma
Sarcoma, Melanoma
Acute Myeloid Leukemia
Lung Cancer
Ovarian Cancer
Merkel Cell Cancer
Target Antigen
NY-ESO-1
EBV
gp100
Others
Key Geographical Regions
North America
Europe
Asia Pacific
Latin America
Middle East and North Africa
Rest of the World
The Global TCR Therapy Market (2nd Edition), 2022-2035 report features the following companies, which we identified to be key players in this domain:
Adaptimmune Therapeutics
Alaunos Therapeutics
Bristol Myers Squibb
Cellular Biomedicine Group
Gilead Sciences
GlaxoSmithKline
Immatics
Immunocore
Lion TCR
Takara Bio
Zelluna Immunotherapy
Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. TCR Therapies: Market Landscape
5. Popular Target Antigen Analysis
6. Clinical Trial Analysis
7. Key Opinion Leaders
8. TCR-based Therapy Profiles
9. Partnerships And Collaborations
10. Funding And Investment Analysis
11. Patent Analysis
12. Case Study: Cell Therapy Manufacturing
13. Cost Price Analysis
14. Market Forecast and Opportunity Analysis
15. Promotional Analysis
16. Company Profiles
17. Concluding Remarks
18. Executive Insights
19. Appendix 1: Tabulated Data
20. Appendix 2: List of Companies and Organizations
To view more details on this report, click on the link:
https://www.rootsanalysis.com/....reports/tcr-based-th
News article
Viral Clearance and Testing Services Market
Learn from experts: do you know about these emerging industry trends?
Adeno-Associated Viral Vectors: Unlocking the Future Opportunities
Modular Construction – Retrofitting Conventional Buildings
Learn from our recently published whitepaper: -
Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com
#tcrbasedtherapies #tcellreceptor #tcr #marketresearch #marketinsights
